Slate Auto says each $24,950 electric pickup truck will be profitable as it aims to be cash-flow positive next year
EV startup Slate Auto CEO Peter Faricy told CNBC that every vehicle the company produces will be gross margin positive....
Author : Douglas L. Grider
FedEx posts strong earnings results in last quarter with freight business
FedEx posted strong fiscal fourth quarter earnings on Tuesday in the company’s last quarter that included the freight business before its spin-off....
‘Reward for failure’: Investor support for Target Chair Brian Cornell falls to lowest level ever
Target Chair Brian Cornell built the retailer into a $100 billion-plus giant, but recent struggles and underperformance have fueled investor calls for change....
SNAP restrictions could change what shoppers buy — and food giants are watching
SNAP food restrictions are spreading to more states, pressuring major food and beverage as consumers shift spending away from soda, candy and processed foods....
Bob Iger reflects on 10 years of Shanghai Disneyland as it defies the Chinese pullback
Shanghai Disneyland hit 100 million cumulative visitors in 2025, according to the company. It’s a relatively new but important foothold in Disney’s history....
NBA to begin naming winning bids for Europe teams in the coming months, deputy commissioner says
The NBA plans to begin naming winning bidders for 12 permanent European teams in the next 60 to 90 days, Deputy Commissioner Mark Tatum told...
California’s counting on an IPO tax windfall. Several factors are complicating the equation
The IPOs of SpaceX, OpenAI and Anthropic could create a tax windfall for the state of California. But experts say the revenue impact may be...
Hollister partners with Target to tap into $89 billion back-to-college shopping market
Hollister’s partnership with Target comes as both companies look to capitalize on the lucrative back-to-college shopping market....
CarMax shares fall after used car retailer reports earnings beats, CEO details turnaround plan
Despite the beats, questions remain about the company’s ability to grow and cut costs under the plan amid tougher market conditions, including margin pressure....
UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application....